Financial News

Recent Quotes

My Watchlist

Indicators

Overview

Grace Therapeutics, Inc. - Common Stock (NQ:GRCE)

2.600 UNCHANGED

Streaming Delayed Price Updated: 3:58 PM EDT, May 13, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	98
Open	2.600
Bid (Size)	2.500 (3)
Ask (Size)	3.080 (3)
Prev. Close	2.600
Today's Range	2.600 - 2.600
52wk Range	1.750 - 4.965
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

March 11, 2025

From Matinas BioPharma Holdings, Inc.

Via GlobeNewswire

Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study

February 10, 2025

Grace Therapeutics' GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission is expected in early 2025.

Via Benzinga

Performance

YTD	-35.0%	-35.0%
1 Month	+21.5%	+21.5%
3 Month	-24.2%	-24.2%
6 Month	-18.5%	-18.5%
1 Year	-19.0%	-19.0%

Frequently Asked Questions

Is Grace Therapeutics, Inc. - Common Stock publicly traded?

Yes, Grace Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Grace Therapeutics, Inc. - Common Stock trade on?

Grace Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Grace Therapeutics, Inc. - Common Stock?

The ticker symbol for Grace Therapeutics, Inc. - Common Stock is GRCE on the Nasdaq Stock Market

What is the current price of Grace Therapeutics, Inc. - Common Stock?

The current price of Grace Therapeutics, Inc. - Common Stock is 2.600

When was Grace Therapeutics, Inc. - Common Stock last traded?

The last trade of Grace Therapeutics, Inc. - Common Stock was at 05/13/25 03:58 PM ET